American Cannabis Company, Inc. (AMMJ) (“ACC”), a full-service business-to-business cannabis and hemp consulting solutions provider, is pleased to announce that it has secured a contract with a new client in Macedonia, a country in the Balkan Peninsula located in Southeast Europe. The company has been retained specifically for conceptual floorplan and facility layout activities in association with providing base equipment lists for cultivation and processing. This thirteen thousand square foot facility will feature a very efficient and lean process flow. The client intends to utilize all harvested material for extraction and oil production, and the operation will have an extraction facility located on site. Working to place both cultivation and extraction operations within the same building footprint, architects assigned to the design process will focus on creating a space that allows for the largest possible plant canopy while at the same time allotting sufficient room for commercial extraction operations to take place.
Tyler Schloesser, Chief Operating Officer for American Cannabis Company, said: “I am thrilled to be engaged with this client as we look to complete conceptual design in a country that ACC has never had the opportunity to work in before. We at ACC are continuing to expand the frontier by offering international cannabis consulting services in all regulated markets. It is a true honor to be participating in this project as we add Macedonia to our seemingly ever-growing list of markets that we have provided top-notch consulting services to.”
Terry Buffalo, American Cannabis Company’s Principal Executive Officer, commented: “This is a very exciting time for our company, as we continue to expand into these new and emerging markets. This project is to take place 5,864 miles from our headquarters in Denver, Colorado, a large step across the pond marking the furthest distance that the company has had to work remotely. The footprints of ACC’s work are becoming more and more prevalent on a global scale, and we look forward to continuing this outward growth.”
About American Cannabis Company, Inc.
American Cannabis Company, Inc. offers end-to-end solutions to existing and aspiring participants in the cannabis industry. We utilize our industry expertise to provide business planning and market assessment services, assist state licensing procurement, create business infrastructure and operational best practices. We aim to continue to grow the Company by taking equity positions in client projects, licensing the American Cannabis Company brand, as well as analyze acquisition opportunities worldwide. American Cannabis Company also developed and owns a portfolio of branded products including: SoHum Living Soils® – Winner of the 2017 High Times S.T.A.S.H Award for “Best Potting Mix”, The Cultivation Cube™ and the High-Density Cultivation System™. We also design and provide other industry-specific custom product solutions. The building and development of our brands and product suite is based on our Geoponics Philosophy, “the art and science of agriculture in soil.”
For more information, please visit:
Forward Looking Statements
This news release contains “forward-looking statements” which are not purely historical and may include any statements regarding beliefs, plans, expectations or intentions regarding the future. Such forward-looking statements include, among other things, the development, costs and results of new business opportunities and words such as “anticipate”, “seek”, intend”, “believe”, “estimate”, “expect”, “project”, “plan”, or similar phrases may be deemed “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. Actual results could differ from those projected in any forward-looking statements due to numerous factors. Such factors include, among others, the inherent uncertainties associated with new projects, the future U.S. and global economies, the impact of competition, and the Company’s reliance on existing regulations regarding the use and development of cannabis-based drugs. These forward-looking statements are made as of the date of this news release, and we assume no obligation to update the forward-looking statements, or to update the reasons why actual results could differ from those projected in the forward-looking statements. Although we believe that any beliefs, plans, expectations and intentions contained in this press release are reasonable, there can be no assurance that any such beliefs, plans, expectations or intentions will prove to be accurate. Investors should consult all of the information set forth herein and should also refer to the risk factors disclosure outlined in our annual report on Form 10-K for the most recent fiscal year, our quarterly reports on Form 10-Q and other periodic reports filed from time-to-time with the Securities and Exchange Commission. For more information, please visit www.sec.gov.